Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svane

Showing results (191-200 of 811) with videos related to

Pageof 82
Sort By:
Acta Endocrinologica|February 1, 1989
Immunoreactive oxytocin and vasopressin in the non-pregnant human uterus and oviductal isthmusS Lundin, A Forman, T Rechberger, et al.
Current Cardiology Reports|January 7, 2021
Symptoms Preceding Sports-Related Sudden Cardiac Death in Persons Aged 1-49 YearsEmma Ritsmer Stormholt, Jesper Svane, Thomas Hadberg Lynge, et al.
Ugeskrift for Laeger|October 11, 2017
[Immunotherapy is cancer treatment with a novel side-effect profile]Maria Kondrup, Louise Raunkilde, Inge Marie Svane, et al.
Oncoimmunology|June 5, 2013
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4<sup>+</sup> T cellsShamaila Munir, Gitte Holmen Andersen, Inge Marie Svane, et al.
The American Journal of Cardiology|November 14, 1997
Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT])C G Ericsson, J Nilsson, L Grip, et al.
Analytical Chemistry|June 13, 2015
Effect of Metals in Biomimetic Dimetal Complexes on Affinity and Gas-Phase Protection of Phosphate EstersSimon Svane, Thomas J D Jørgensen, Christine J McKenzie, et al.
Vaccine|July 12, 2008
Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2Inge Marie Svane, Anders E Pedersen, Kirsten Nikolajsen, et al.
Reviews of Physiology, Biochemistry and Pharmacology|October 12, 2011
Cardiac ion channels and mechanisms for protection against atrial fibrillationMorten Grunnet, Bo Hjorth Bentzen, Ulrik Svane Sørensen, et al.
Urologic Oncology|August 10, 2015
Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?Per Kongsted, Inge Marie Svane, Henriette Lindberg, et al.
The Lancet. Oncology|October 30, 2025
Tumour-infiltrating lymphocyte therapy comes of age in the era of genetic engineeringMichael D Crowther, Joel E Sohlin, Inge Marie Svane, et al.
Pageof 82

Showing results (191-200 of 811) with videos related to

Sort By:
Pageof 82
Acta Endocrinologica|February 1, 1989
Immunoreactive oxytocin and vasopressin in the non-pregnant human uterus and oviductal isthmusS Lundin, A Forman, T Rechberger, et al.
Current Cardiology Reports|January 7, 2021
Symptoms Preceding Sports-Related Sudden Cardiac Death in Persons Aged 1-49 YearsEmma Ritsmer Stormholt, Jesper Svane, Thomas Hadberg Lynge, et al.
Ugeskrift for Laeger|October 11, 2017
[Immunotherapy is cancer treatment with a novel side-effect profile]Maria Kondrup, Louise Raunkilde, Inge Marie Svane, et al.
Oncoimmunology|June 5, 2013
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4<sup>+</sup> T cellsShamaila Munir, Gitte Holmen Andersen, Inge Marie Svane, et al.
The American Journal of Cardiology|November 14, 1997
Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT])C G Ericsson, J Nilsson, L Grip, et al.
Analytical Chemistry|June 13, 2015
Effect of Metals in Biomimetic Dimetal Complexes on Affinity and Gas-Phase Protection of Phosphate EstersSimon Svane, Thomas J D Jørgensen, Christine J McKenzie, et al.
Vaccine|July 12, 2008
Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2Inge Marie Svane, Anders E Pedersen, Kirsten Nikolajsen, et al.
Reviews of Physiology, Biochemistry and Pharmacology|October 12, 2011
Cardiac ion channels and mechanisms for protection against atrial fibrillationMorten Grunnet, Bo Hjorth Bentzen, Ulrik Svane Sørensen, et al.
Urologic Oncology|August 10, 2015
Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?Per Kongsted, Inge Marie Svane, Henriette Lindberg, et al.
The Lancet. Oncology|October 30, 2025
Tumour-infiltrating lymphocyte therapy comes of age in the era of genetic engineeringMichael D Crowther, Joel E Sohlin, Inge Marie Svane, et al.
Pageof 82